BridgeMD
New treatment option for Cerebral Palsy (CP)
Official title Bootle Blast: Pilot Randomized Controlled Trial
ClinicalTrials.gov ID: NCT07289360
What this study is testing
- What it's testing
- One in 500 Canadians has cerebral palsy (CP), a lifelong condition affecting movement and function. Physical and occupational therapies greatly benefit children with CP but can be costly and difficult to access.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 17
You may be able to join if
- Diagnosis of hemiplegic Cerebral Palsy
- MACS levels I (handles objects easily) to III (handles objects with difficulty)
- Aged 6 to 17 years with sufficient cognitive capacity and cooperation to play Bootle Blast and complete outcome assessments
- Ability to communicate in English
- Able to travel to Holland Bloorview, Grandview or CHEO and complete a total of 3 in-person study appointments
You likely can't join if
- Received upper limb surgery, botulin toxin injections in the past 4 months, or constraint therapy/casting in the previous 3 months that may be...
- Currently or anticipates receiving active treatments impacting upper limb function during the study period
- Uncontrolled epilepsy that may be triggered by video game play
- Medical condition impeding safe participation in physical activity associated with Bootle Blast
- Visual limitations that interfere with Bootle Blast play
See the full eligibility criteria
- Diagnosis of hemiplegic Cerebral Palsy
- MACS levels I (handles objects easily) to III (handles objects with difficulty)
- Aged 6 to 17 years with sufficient cognitive capacity and cooperation to play Bootle Blast and complete outcome assessments
- Ability to communicate in English
- Able to travel to Holland Bloorview, Grandview or CHEO and complete a total of 3 in-person study appointments
- Has a large screen (e.g. TV) with an appropriate play space (3m x 3m) in front
- At least intermittent access to the internet
- Have time to play Bootle Blast for 15-20 minutes/day, 3-4 days/week for 12 weeks.
- Received upper limb surgery, botulin toxin injections in the past 4 months, or constraint therapy/casting in the previous 3 months that may be associated with changing abilities
- Currently or anticipates receiving active treatments impacting upper limb function during the study period
- Uncontrolled epilepsy that may be triggered by video game play
- Medical condition impeding safe participation in physical activity associated with Bootle Blast
- Visual limitations that interfere with Bootle Blast play
The study team makes the final eligibility decision.
Where it's taking place
- Ajax, Ontario, Canada
- Ottawa, Ontario, Canada
- Toronto, Ontario, Canada
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ajax, Ontario, Canada; Ottawa, Ontario, Canada; Toronto, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.